SCHEMBL8992390

SCHEMBL8992390

C=CCOC(=O)C(c1ccc(C)cc1)c1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
MAPT P10636 2/20 0.42
TK1 P04183 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CHRM2 P08172 2/20 0.38
CHRM4 P08173 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
TSHR P16473 1/20 0.38
STAT3 P40763 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
HPGD P15428 2/20 0.38
ACHE P22303 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9296625 0.84 ALDH1A1 (0.44) CYP3A4NPSR1ALDH1A1HSD17B10CHRM2
SCHEMBL11598437 0.83 CYP2C19 (0.44) CYP3A4NPSR1ALDH1A1HSD17B10CHRM2
SCHEMBL9230354 0.82 CYP3A4 (0.55) CYP3A4TK1NPSR1L3MBTL1ALDH1A1
SCHEMBL3541681 0.80 MEN1 (0.49) CYP3A4L3MBTL1ALDH1A1CHRM2CHRM4
SCHEMBL27880966 0.76 NPSR1 (0.44) CYP3A4MAPTNPSR1ALDH1A1HSD17B10
P-Xylene SCHEMBL11403520 0.75 CYP3A4 (0.46) CYP3A4MAPTNPSR1L3MBTL1ALDH1A1
SCHEMBL9270334 0.75 SNCA (0.58) CYP3A4MAPTALDH1A1HSD17B10TSHR
SCHEMBL7724618 0.74 MAPT (0.38) CYP3A4MAPTNPSR1ALDH1A1HSD17B10
SCHEMBL5084136 0.74 LMNA (0.55) CYP3A4L3MBTL1ALDH1A1CHRM2CHRM4
SCHEMBL5282428 0.74 L3MBTL1 (0.51) L3MBTL1ALDH1A1CNR1CNR2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0445749-B1 N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 1996-07-10 EP disclosed
US-5256824-A Anticholinergic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-26 US disclosed
EP-0445749-A1 N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-09-11 EP disclosed